Deltex Medical Group plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DTXMF research report →
Price Chart
About the company
Deltex Medical Group plc, with its global presence encompassing the United Kingdom, the United States, Spain, and Canada, is dedicated to the development, marketing, and distribution of its TrueVue brand of esophageal Doppler hemodynamic monitoring systems. The company's innovative product lineup features: Esophageal Doppler Probes: These probes are engineered to accurately gauge a patient's central vascular blood flow and fluid status by continuously measuring real-time blood velocities within the descending aorta. Loops plots: This technology provides dynamic visualization of aortic blood flow velocity and aortic blood pressure, tracked meticulously with every single heartbeat.
- CEO
- Natalie Emilia Wettler
- IPO
- 2009
- Employees
- 24
- HQ
- Chichester, GB
Get TickerSpark's AI analysis on DTXMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $180.58M
- P/E
- -0.22
- PEG
- -0.00
- P/S
- 0.37
- P/B
- 0.09
- EV/EBITDA
- -1.88
- Div Yield
- 0.00%
- Gross Margin
- 63.34%
- Op Margin
- -59.23%
- Net Margin
- -72.18%
- ROE
- -45.48%
- ROIC
- -19.24%
Latest fiscal year · YoY change
- Revenue
- $2.06M+15.8%
- Gross Profit
- $1.40M+24.3%
- Op Income
- $-1,586,000
- Net Income
- $-1,797,000-40.2%
- EPS
- $-0.00+18.2%
- OCF Growth
- +59.7%
- FCF Growth
- +68.7%
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.10
- 200D MA
- $0.10
- Beta
- -2.06
- RSI (14)
- 100
- Avg Volume
- 44.61K
No earnings-call transcripts are available for DTXMF yet.
- Free Float
- 42.3%
- Shares Outstanding
- 1.90B
- Float Shares
- 802.55M
Our DTXMF coverage
Recent articles, reports, and earnings notes.
No research on DTXMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DTXMF report →Deltex Medical shares plunge 50% on proposed AIM cancellation and CEO resignation
proactiveinvestors.co.uk · Jan 16
Deltex Medical slips despite chairman optimism
proactiveinvestors.co.uk · Jul 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.